Subscribe To

Price Alert Latest News Economic Calendar News

CBT / Cabot Corporation (CBT) Q4 2022 Earnings Call Transcript

Cabot Corporation (NYSE:CBT ) Q4 2022 Earnings Conference Call November 8, 2022 8:00 AM ET Company Participants Steve Delahunt - Vice President of Investor Relations & Treasurer Sean Keohane - President & Chief Executive Officer Erica McLaughlin - Senior Vice President & Chief Financial Officer Conference Call Participants Anthony Mercandetti - Deutsche Bank James Cannon - UBS Jeff Zekauskas - JPMorgan Laurence Alexander - Jefferies Chris Kapsch - Loop Capital Operator Ladies and gentlemen, thank you for standing by and welcome to Cabot's Fourth Quarter 2022 Earnings Conference Call. [Operator Instructions] Please be advised today's conference may be recorded. Read More

Demo Live Account See Partner Details

Content Topics

Cabot

Corporation

CBT

2022

Earnings

Call

Transcript

Stock

Posted: Nov 8 2022, 14:27

Author Name: Seeking Alpha

CBT News

By Zacks Investment Research
September 19, 2023

Cabot (CBT) Boosts Circularity & Traceability With ISCC PLUS

Cabot's (CBT) ISCC PLUS certified facilities adhere to ISCC PLUS requirements by leveraging circular value chains and certified feedstocks in the prod

By Zacks Investment Research
September 6, 2023

Why Is Cabot (CBT) Up 2.2% Since Last Earnings Report?

Cabot (CBT) reported earnings 30 days ago. What's next for the stock?

By Zacks Investment Research
August 15, 2023

Cabot (CBT) Joins US Energy Department's Better Plants Program

Cabot (CBT) believes that this engagement with the DOE will help the company boost its energy efficiency performance.

By Seeking Alpha
August 9, 2023

Cabot: The Low Upside Potential Discourages Purchases

Cabot Corp. is a global specialty chemicals and performance materials company, with a significant presence in international markets. Weakening global

By Zacks Investment Research
August 8, 2023

Cabot (CBT) Q3 Earnings & Revenues Miss Estimates, Fall Y/Y

Cabot (CBT) lags third-quarter earnings and revenue estimates due to low volumes in its segments.

By Zacks Investment Research
August 7, 2023

Compared to Estimates, Cabot (CBT) Q3 Earnings: A Look at Key Metrics

Although the revenue and EPS for Cabot (CBT) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering

By Business Wire
July 10, 2023

Cabot Corporation to Announce Third Quarter 2023 Operating Results

BOSTON--(BUSINESS WIRE)--Cabot Corporation to Announce Third Quarter 2023 Operating Results.

By Zacks Investment Research
June 19, 2023

Cabot (CBT) Announces Updates on Current Demand Scenario

Cabot (CBT) expects EBIT in the Performance Chemical segment to be slightly higher in the fiscal third quarter than in the second quarter.

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.